NCT01864772 2022-08-19
ELANFIT
Groupe Oncologie Radiotherapie Tete et Cou
Phase 2 Completed
Groupe Oncologie Radiotherapie Tete et Cou
Yonsei University
Galectin Therapeutics Inc.
Stanford University
Merck KGaA, Darmstadt, Germany
Sun Yat-sen University
Shanghai Jiao Tong University School of Medicine
National Taiwan University Hospital